Abivax ABVX
NASDAQ ABVX
$91.44 +1.44 (+1.60%)
At close: Nov 11, 2026 · 4:00 PM EST

Abivax (ABVX) Current Taxes (2021 - 2025)

Updated

Abivax (ABVX) reported Current Taxes of $4.89 million for Q3 2025, down 82.8% from the prior quarter.

Analysis

Abivax (ABVX) Current Taxes (2021 - 2025) Analysis & Trends

At the end of FY2024, Abivax posted Current Taxes of $22.45 million, down 31.5% from FY2023.

  • Current Taxes has a three-year compound annual growth rate of 216.5% (FY2021 to FY2024).
  • By year, Current Taxes came in at $32.77 million in FY2023 (+54.0%), $21.28 million in FY2022 and $707,814 in FY2021.
  • The Q3 2025 figure ranks as the lowest quarterly Current Taxes since Q4 2021.
  • Per Business Quant data, the three quarters before Q3 2025 came in at $28.38 million (Q2 2025), $21.94 million (Q1 2025) and $22.45 million (Q4 2024).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Taxes (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 1.98 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.31 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.62 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 438.00 Mn
10 Abivax 7.07 Bn 4.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 4.89 Mn
Jun 30, 2025 28.38 Mn
Mar 31, 2025 21.94 Mn
Dec 31, 2024 22.45 Mn
Jun 30, 2024 26.57 Mn
Dec 31, 2023 32.77 Mn
Dec 31, 2022 21.28 Mn
Dec 31, 2021 707,814.25
API Access

Abivax Current Taxes API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-taxes&ticker=ABVX&period=max&api_key=YOUR_API_KEY